Navigation Links
OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
Date:6/6/2008

SAN FRANCISCO, June 6 /PRNewswire/ -- OxyBand Technologies Inc., San Francisco, has hired Dr. Olivier Postel to lead the company's bio-medical technology development and expand the company's intellectual property portfolio. OxyBand develops innovative therapeutic gas technology for health, cosmetic and consumer care. The company's inaugural device is an oxygen wound healing dressing, cleared by the FDA for medical and over the counter marketing. OxyBand has received a contract from the US Army.

The extensive experience Dr. Postel brings with him as Chief Technology Officer will help to focus the company's efforts in research and development, manufacturing and marketing toward launching new products in the market place.

Prior to joining OxyBand, Dr. Postel was the Director of Process Engineering and Integration at dpiX, the world leader of sensor arrays for X- ray medical imaging, where among his other responsibilities, he lead the engineering start-up of a $100 MM expansion facility in Colorado Springs, supported by four global medical equipment companies, Varian Medical Systems, Phillips Medical Systems, Siemens A.G. and Thales.

Dr. Postel has an extensive background in space propulsion systems and gas chemistry, beginning his career as a Staff Scientist at Stanford University's Plasma Propulsion Lab. He later leveraged his expertise in these fields and founded a medical device start up in Cold Plasma device technology for cosmetic and wound care funded in part by NIH. Dr. Postel has served on an NIH review committee on Infectious Diseases and Microbiology for the past several years. Dr. Postel has also worked with other Silicon Valley start-ups of various stages in developing technology.

The market is ready for OxyBand's innovative technology solutions. Dr. Postel's addition to the OxyBand team will help the company to become a market leader.

"We are very pleased Olivier has joined our team and we hope to capitalize on his
'/>"/>

SOURCE OxyBand Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
3. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
4. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
5. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
6. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. Wound Management Technologies, Inc. Announces Evidence Based Study
9. Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
10. Hospital to Hold MRSA Briefing for Media and Community Leaders
11. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Calif., Nov. 30 StemCyte, Inc. c...n agreement with Academia Sinica, the National Lab... and Intellectual Property (IP) related to the tre...thod and IP was pioneered by a team led by Profess...a. Professor Lin is currently the exclusive colla...
(Date:11/30/2009)...W YORK, Nov. 30 Reportlinker.com a...lable in its catalogue: ,, Inflammatory Disord... Response ,, http://www.reportlinker.com/p016...s-or-Balance-the-Immune-Response.html ,, The h...n individual body or producing an exaggerated resp...
(Date:11/30/2009)...N, Ill., Nov. 30 The Simmons law f...cated to representing thousands of women that were...popular birth control pill manufactured and market...al Panel on Multidistrict Litigation has ordered t...lawsuits be consolidated and centralized for pretr...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Simmons Firm's Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer 2ChristianPF com Offers Four Tips to Lower Prescription Drug Costs 52667 1Ovary Removal May Play a Role in Lung Cancer 52665 1Ovary Removal May Play a Role in Lung Cancer 52665 2Cyberonics Provides Update on Depression Post Approval Study 4778 1Cyberonics Provides Update on Depression Post Approval Study 4778 2Cyberonics Provides Update on Depression Post Approval Study 4778 3
...at DDW Demonstrate Linaclotide Provided Early Onse...ts -- , , CAMBRIDGE, Mass. and NEW YORK, May 31, ...boratories, Inc. (NYSE: FRX ) today announced re...tudy assessing the safety and efficacy of the nove...s with irritable bowel syndrome with constipation ...
...n double risk of cancer recurrence in tamoxifen tr...fen users take drugs that reduce its effectiveness... An important new study finds that certain popular...king the breast cancer drug tamoxifen more than do...ose using both medications. The research presente...
Other Medicine Technology:Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 6New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 2New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 3New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 4New Study: Antidepressants Commonly Prescribed with Tamoxifen Put Women at Much Higher Risk for Recurrent Breast Cancer 5
(Date:12/1/2009)...el Jordan Fiddle Foundation, a national autism org...r, and support programs and services for adolescen..., has released a free informational brochure entit... Recognize The Signs and Basic First Aid When You ...(PRWEB) December 1, 2009 -- Statistics show that a...
(Date:12/1/2009)... Cell Therapeutics, Inc....ation at the 21st Annual Piper Jaffray Health Care...astern Time will be webcast live at www.cellthera...lace in Holmes 1 at the New York Palace Hotel, and...ntation. , , Piper Jaffray H...
(Date:12/1/2009)...l magnetic resonance imaging (fMRI) to evaluate br... to lead as children incur permanent brain injury....eting of the Radiological Society of North America... of the brain is spared from lead exposure," said ... scientist at Cincinnati Children,s Hospital Medic...
(Date:11/30/2009)...st Fertility is attempting to dispel the notion th...nd send patients home pregnant with multiples. Wh...nt, their priority is health and safety. In addit...s can put on a country’s healthcare system. ... 2009 -- Many patients and doctors in the U.K. wor...
(Date:11/30/2009)...swire/ -- Low-dose radiation from annual mammograp...men with genetic or familial predisposition to bre...t the annual meeting of the Radiological Society o...risk for breast cancer, screening is very importan...sidering mammography for screening young women, pa...
Breaking Medicine News(10 mins):Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:Childhood lead exposure causes permanent brain damage 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 2Health News:Mammography May Increase Breast Cancer Risk in Some High-Risk Women 3
...d a mystery how even in loud environments - like a...usic and a cacophony of people// talking - we can ... showed that the brain chooses what to hear. N...e the retina, this mapping is point-for-point. Thu...
...chers at the University of California, San Diego (...y be caused by cycles of liver cell// death and re..., appearing online the week of June 19 in advance ... proliferation. The findings by Michael Karin, Ph....
...isease that is characterized by a reduction in the...ty to bone deformities// and fractures. It affe... age of 50 years. At the Harvard School of Public...ass. The results may have profound implications in...
...he latest edition of the Annals of the New York Ac...c has evolved over the years// and how humans are ...that animals like birds, dolphins, and whales make... is necessary for the development of language, and...
...orm people of the expiry of perishable food items ...l this move is risky. // Freshness dating c...ng article in this month's Journal of Food Science...by" date, people rate the food as less tasty and l...
...dy's Laboratories today announced that it has laun...scar tablets 5 mg (Finasteride) on June 19. // ...neric version of Merck's Zocor tablets (Simvastati...h Merck that enabled it to launch the authorized g...
Other Medicine News:Health News:Sound Separated into Sound Frequencies 2Health News:Sound Separated into Sound Frequencies 3Health News:Repeated Liver Cell Proliferation, a Cause for Liver Cancer 2Health News:Research Identifies Osteoporosis Controlling Protein 2
Anterior Chamber PMMA One-Piece Lens
...erior Chamber Intraocular Lenses are intended for ...ars of age or older where a cataractous lens has b...action; or primary extracapsular cataract extracti...erior chamber lens would be the preferred one; or ...
...IOL is a foldable silicone IOL. It features a 6.0-...serted with The UNFOLDER® Silver-T Implantatio...st and only FDA-approved multifocal IOL, and the f...visionnear, intermediate, and far. The ARRAY® ...
BioLon
Medicine Products: